Biermann Niklas, Chak Juy Chi, Wiesmeier Anna, Klein Silvan M, Ruewe Marc, Spoerl Steffen, Kruppa Philipp, Prantl Lukas, Anker Alexandra M
Department of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, D-93053 Regensburg, Germany.
Clinic and Polyclinic for Oral and Maxillofacial Surgery, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, D-93053 Regensburg, Germany.
Life (Basel). 2024 Jan 3;14(1):82. doi: 10.3390/life14010082.
This systematic review addresses the crucial role of anticoagulation in microsurgical procedures, focusing on free flap reconstruction and replantation surgeries. The objective was to balance the prevention of thrombotic complications commonly leading to flap failure, with the risk of increased bleeding complications associated with anticoagulant use. A meticulous PubMed literature search following Evidence-Based-Practice principles yielded 79 relevant articles, including both clinical and animal studies. The full-texts were carefully reviewed and evaluated by the modified Coleman methodology score. Clinical studies revealed diverse perioperative regimens, primarily based on aspirin, heparin, and dextran. Meta-analyses demonstrated similar flap loss rates with heparin or aspirin. High doses of dalteparin or heparin, however, correlated with higher flap loss rates than low dose administration. Use of dextran is not recommended due to severe systemic complications. In animal studies, systemic heparin administration showed predominantly favorable results, while topical application and intraluminal irrigation consistently exhibited significant benefits in flap survival. The insights from this conducted systematic review serve as a foundational pillar towards the establishment of evidence-based guidelines for anticoagulation in microsurgery. An average Coleman score of 55 (maximum 103), indicating low overall study quality, however, emphasizes the need for large multi-institutional, randomized-clinical trials as the next vital step.
本系统评价探讨了抗凝在显微外科手术中的关键作用,重点关注游离皮瓣重建和再植手术。目的是在预防通常导致皮瓣失败的血栓形成并发症与使用抗凝剂相关的出血并发症增加风险之间取得平衡。按照循证实践原则对PubMed进行细致的文献检索,得到79篇相关文章,包括临床和动物研究。通过改良的科尔曼方法评分对全文进行仔细审查和评估。临床研究揭示了多种围手术期方案,主要基于阿司匹林、肝素和右旋糖酐。荟萃分析表明,肝素或阿司匹林的皮瓣丢失率相似。然而,高剂量达肝素或肝素与低剂量给药相比,皮瓣丢失率更高。由于严重的全身并发症,不建议使用右旋糖酐。在动物研究中,全身给予肝素主要显示出有利结果,而局部应用和腔内冲洗在皮瓣存活方面始终显示出显著益处。本次系统评价所得出的见解是制定显微外科抗凝循证指南的基础支柱。然而,平均科尔曼评分为55分(满分103分),表明总体研究质量较低,这强调了大型多机构随机临床试验作为下一步关键举措的必要性。